We have all heard stories about mythical creatures that are half human, half animal — Pan, the Minotaur, Medusa, centaurs, merfolk, angels, faeries. We dismiss the very idea as fantasy. Today, our own civilisation is at the cusp of creating a raft of animal–human hybrids. Laws have been changed to allow for it. The first experiments are already under way.
The notion that these creatures once roamed the earth would make people smirk at you at best, or commit you to an institution with padded walls at worst. It is simply too far removed from our accepted reality to even consider the possibility. And yet, here we are.
To clarify what we are talking about: species are defined as groups of living organisms consisting of similar individuals capable of exchanging genes or interbreeding. A hybrid animal occurs when parents from two different — but usually closely related — species produce offspring. Hybrid offspring are typically infertile and unable to reproduce, though there are exceptions. With scientific intervention, including artificial insemination, it is possible to create a breeding line of hybridised animals that are actually fertile.
Known Hybrid Animals — A Sample Set
MuleCross of female horse and male donkey
HinnyCross of female donkey and male horse
Zeedonk / ZonkeyZebra / donkey cross
ZorseZebra / horse cross
Zony / ZetlandZebra / pony cross
Dzo / Zo / YakowDomestic cow and yak
BeefaloAmerican bison and domestic cow — fertile breed
ZubronWisent (European bison) and domestic cow
YakaloBison and yak hybrid
WholphinFalse killer whale and bottlenose dolphin — fertile but rare
Liger / TigonLion and tiger cross, and other Panthera hybrids
Hybrid OrangutanBornean and Sumatran orangutan cross
Homo sapiens / NeanderthalLiving humans carry Neanderthal genes — hybridisation in our past
The Ad That Started It — What Followed the Research
◆ Research Discovery — Noted During Show Prep
When research for this show topic began, targeted ads appeared in the browser. Following those links led to two discoveries that significantly shaped the direction of this series: a genetic testing platform, and then a commercial CRISPR genome editing service — available, openly advertised, and aimed at researchers. That second link changed everything about how this topic needed to be framed.
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a gene editing technology first discovered in bacteria in the 1980s. Its potential for editing the genomes of other organisms — including humans — was not fully understood until the 2000s. Scientists Jennifer Doudna and Emmanuelle Charpentier made the breakthrough discovery in 2005, identifying the key components of the CRISPR system, specifically an RNA molecule that could guide the Cas9 protein to a specific target DNA sequence for precise editing.
In 2012, Doudna and Charpentier published a landmark paper in the journal Science outlining the CRISPR-Cas9 system's potential for RNA-programmed genome editing. The discovery earned them the Nobel Prize in Chemistry in 2020 — awarded just seven years after the initial publication, which is extraordinarily fast by Nobel standards.
How it works
CRISPR is an immune system used by microbes to find and eliminate viral invaders. When a virus infects a bacterial cell, the bacterium incorporates some of the virus's DNA into its own genome so it can recognise and destroy the virus in future infections. Scientists have adapted this system as a tool — essentially a programmable pair of molecular scissors — that can locate and cut specific sequences of DNA in any organism with unprecedented precision. The "address" of the cut is encoded in a guide RNA, which can be redesigned in days at minimal cost, unlike previous gene editing tools that required redesigning entire proteins.
Stanford on CRISPR — June 2024
Stanford University bioengineer Stanley Qi described CRISPR not merely as a tool for research but as "a discipline, a driving force, and a promise that solves long-standing challenges from basic science, engineering, medicine, and the environment." The technology has moved from laboratory curiosity to approved clinical drug in roughly a decade — the first CRISPR drug, Casgevy, was approved by the FDA to treat sickle cell anaemia and beta thalassemia, conditions previously requiring lifelong blood transfusions or bone marrow transplants.
Beyond medicine
CRISPR applications span diagnostics, crop engineering for disease resistance, creation of disease-resistant livestock, and ecological engineering including attempts to revive extinct species. The technology has also been proposed as a universal antiviral system — its original role in bacteria. Researchers have even created miniaturised versions of the Cas9 molecule, dubbed CasMINI, which are small enough to be delivered inside cells via retooled viruses, opening pathways to in-body treatments that current delivery methods cannot reach.
◆ Documented Benefits
- Precision gene editing at unprecedented accuracy
- Treatment of sickle cell anaemia, cystic fibrosis, muscular dystrophy
- Cancer therapy development targeting tumour-specific genes
- Agricultural advances — disease-resistant and higher-yield crops
- Disease-resistant livestock reducing antibiotic dependency
- Stem cell and regenerative medicine applications
- Infectious disease diagnostics and pathogen research
- Evolutionary and functional genomics research
- Sustainable bioengineering — carbon-neutral food production
- Potential universal vaccine platform
◆ Documented Concerns
- Designer babies — heritable edits affecting future generations
- Off-target effects — unintended genetic changes
- Unknown long-term consequences in edited individuals
- Socioeconomic disparity — unequal access to gene therapies
- Environmental impact from releasing modified organisms
- Regulatory frameworks cannot keep pace with developments
- Dual-use risk — engineered pathogens as weapons
Human–Animal Hybrids in History and Mythology
For thousands of years, human–animal hybrids have been one of the most common themes in storytelling across every culture on earth. The lack of a strong divide between humanity and animal nature in multiple traditional and ancient cultures has provided the underlying context for the popularity of these beings — creatures who transform, mingle, or embody both worlds simultaneously.
Scholar Pietro Gaietto has argued that representations of human–animal hybrids always have their origins in religion — and that in successive traditions they may change in meaning but remain within spiritual culture. The beings appear in Greek, Roman, Egyptian, Chinese, Japanese, Anatolian, and Mesopotamian mythologies.
◆ Notable Mythological Hybrids
Pan — Greek deity of the untamed wild, a Satyr with the hindquarters, legs, and horns of a goat. Worshipped by hunters, fishermen, and shepherds. Mischievous yet cheerful. His stories have been retold for centuries.
Anubis — Egyptian god of death with canine-like features. One of the earliest recorded human–animal hybrid deities.
The Sphinx — Lion-bodied with a human head. Central to ancient Egyptian religion.
Kitsune — Fox-like Japanese beings with shape-shifting powers, able to transform into seductive humans. Stories of them tricking men into marriage persist across centuries of Japanese culture.
Tanuki — Raccoon or badger-like beings whose shape-shifting allows them to impersonate Buddhist monks.
Chu Pa-chieh (Zhu Bajie) — Chinese mythology. A man exiled to earth who enters the womb of a sow and is born half-human, half-pig. Professor Victor Mair has noted that pig–human hybrids in Chinese tradition represent descent and "a capitulation to the basest appetites" rather than self-improvement.
Pazuzu — Mesopotamian demon with a humanoid shape and grotesque animal features including sharp talons.
The modern understanding of human–animal hybrids spans a spectrum: from the literary and cinematic (H.G. Wells' The Island of Doctor Moreau, adapted as the 1932 film Island of Lost Souls) to the legally and scientifically contested. The magazine H+ defines such hybrids as "genetic alterations that are blendings of animal and human forms." They are also referred to as para-humans, humanised animals, or cybrids — cytoplasmic hybrids featuring foreign human nuclei inside non-human cells.
Despite the cultural weight of these stories, the notion of real human–animal hybrids remained in the domain of legend and thought experiment until very recently. Then, in 2003, scientists at Shanghai Second Medical University created the first stable human–animal chimeras — fusing human cells with rabbit eggs. The question shifted from could it be done? to what should we allow?
Then-President George W. Bush specifically addressed the issue in his 2006 State of the Union address. The state of Arizona banned the practice outright in 2010. A proposal that generated interest in the US Senate from 2011 to 2012 went nowhere. The world was beginning to notice — and beginning to disagree.
The Dark History — Ilya Ivanovich Ivanov
Ilya Ivanovich Ivanov
Soviet Biologist · Pioneer of Artificial Insemination
Born: 1 August 1870, Shigry, Kursk Province, Russia · Died: 20 March 1932, Alma-Ata, Kazakh S.S.R.
Ivanov established several zoological laboratories in Moscow in 1898, studying the vital processes of sex organs in farm animals. He concluded that the single condition necessary for impregnation was the union of spermatozoon and egg, and that spermatozoa retain their motility for a period if properly preserved. He developed techniques for obtaining, preserving, and disinfecting semen, and devised a procedure for artificial insemination usable across all types of livestock.
In 1901, Ivanov founded the world's first centre for artificially impregnating horses at Dolgoe Village. He then turned to interspecies hybridisation — crossbreeding domestic animals with wild varieties. He produced a zeedonk (zebra–donkey), a zubron (European bison–cow cross), and various rodent combinations. At a gathering of zoologists in 1910, he told colleagues it might be possible to create hybrids between humans and their closest relatives.
At the time it was speculation. A decade and a revolution later, he was making plans to put theory into practice.
In 1924, Ivanov put his proposals to the Soviet government. Despite the disapproval of the scientific establishment, the go-ahead was pushed through by leading Bolshevik party members. The official justification: proving Darwin's theory of evolution, which would strike a blow against religion the Bolsheviks were struggling to eradicate.
Historian Alexander Etkind of Cambridge University, who examined scattered letters, notebooks, and diaries from government archives, believes there was a third motive. The high-ranking Bolsheviks who backed Ivanov were intellectuals who saw science as a means of realising their dream of a socialist utopia. "Politicians could change the political system, nationalise industries and turn farms into vast collectives," Etkind observed, "but the task of transforming people was entrusted to scientists." The aim was to use positive eugenics — including artificial insemination — to speed up the spread of desirable traits and eliminate competitive or individualistic ones. Ivanov's experiment was the most extreme version of this ambition.
◆ The Africa Expedition, 1926
In February 1926, Ivanov departed for Guinea in French West Africa. His first stop was Paris, where he secured the support of the directors of the Pasteur Institute and access to chimpanzees at their primate centre. He arrived in Guinea in late March to find none of the chimpanzees mature enough to breed. He would have to return.
While waiting in Paris, Ivanov spent time with the celebrated surgeon Serge Voronoff — inventor of a fashionable "rejuvenation therapy" involving the grafting of ape testes into ageing men. That summer, Ivanov and Voronoff made headlines by transplanting a woman's ovary into a chimpanzee called Nora and inseminating her with human sperm. The press was fascinated. Was it possible? Were humans really that closely related to apes? What were the Soviets up to?
In November, Ivanov returned to Guinea, captured chimpanzees, and with considerable difficulty inseminated three of them. He then conceived a second experiment: to inseminate African women with chimpanzee sperm — initially planned under the guise of a medical examination. The French colonial governor refused permission.
None of the three chimpanzees conceived. Ivanov returned to the Soviet Union with twenty chimpanzees to stock a new primate facility in the subtropical republic of Abkhazia. He began looking for Soviet women willing to volunteer for the reverse experiment.
At least five women volunteered. But the available apes never flourished, and by the time Ivanov was ready, the only adult male remaining was Tarzan — a 26-year-old orang-utan. Ivanov pressed on until Tarzan suffered a brain haemorrhage. More chimpanzees arrived in 1930, but Ivanov fell victim to a widespread purge of scientists and was exiled to Kazakhstan. He was released the following year but died shortly after.
"Five women offered to carry half-ape babies in the interests of science."
— New Scientist, Stephanie Pain, 2008
The 1920s Soviet experiment was not the only attempt. A secret research facility in Florida, Chinese state-sanctioned programs, a performing chimpanzee who seemed too human to be explained — the story of the humanzee has more chapters than the official record admits.
The Humanzee — Science Playing God
Evolutionary psychologist Gordon Gallup stated that in the 1920s the first humanzee was born at a secret research facility in Florida. Gallup himself was not alive at the time — he was told this by his professor, who had spent thousands of hours researching the possibility of such a hybrid. Gallup reports the humanzee was killed soon after birth due to the pressure the research team received for their experiment.
The chimpanzee shares approximately 99% of coding DNA sequences with humans, making it the species with the closest biological architecture to our own. Technology in the 1920s was not sufficient for laboratory gene manipulation — what Gallup's professor described was simpler and more disturbing: scientists inseminated a female chimpanzee with human semen from an anonymous donor. The chimpanzee became pregnant, and by Gallup's account, gave birth to a healthy hybrid. There are rumours the hybrid was able to say a few words in English and demonstrated cognitive abilities well above those of a typical chimpanzee.
The scientists, confronted with what they had produced, were overwhelmed by moral and ethical pressure. The humanzee was killed. What happened to the documentation is unknown.
◆ A Chronology of Attempts
1920s — Florida (alleged): First humanzee reportedly born and killed at an unnamed US research facility, according to Gallup's account of his professor's research.
1967 — China: According to Ji Yongxiang, head of a hospital in Shenyang, the People's Republic of China made an attempt. Reports — confirmed by the Chinese Academy of Sciences — suggest this experiment produced results, including a hybrid reportedly able to fluently communicate in a taught language from a young age.
1981 — China: The Chinese Academy of Sciences confirmed a second experiment in which a female chimpanzee was impregnated with human sperm. The chimpanzee became pregnant but died three months later due to health complications.
1990s: Various experiments attempted combining human cells with pig and sheep cells.
2019: Unconfirmed reports, attributed to sources at the Salk Institute for Biological Studies in the United States, suggest a team of researchers from Spanish medical universities produced the first half-human, half-monkey hybrid — conducted in China to avoid legal issues at home.
Oliver — The Chimpanzee Who Made People Wonder
In the 1970s, a performing chimpanzee named Oliver became internationally known. His act was distinctive — he understood human commands with an accuracy that strained explanation, walked bipedally as a preference rather than a last resort, and behaved in ways observers described as fundamentally more human than animal. His managers publicly marketed him in the 1980s as a possible human–chimpanzee hybrid, which attracted significant public attention.
In 1986, the University of Chicago brought Oliver in for genetic analysis. The results were definitive: Oliver was a normal chimpanzee. Subsequent research confirmed this through the American Journal of Physical Anthropology. He was not a hybrid — but the episode demonstrated how attuned people are to detecting something different in the behaviour of an animal that has spent its life embedded in human company, and how quickly speculation follows.
Chimeras Created by Science — Five Documented Cases
A chimera is an organism containing genetic material from two or more different sources. While hybrids result from the interbreeding of two species, chimeras are created by inserting cells of one organism into the developing embryo of another. Experiments in the field may save lives — but are ethically contested at every step.
◆ Documented Chimera Experiments
Human–Monkey (2019, China): Researchers led by Spanish scientist Juan Carlos Izpisua Belmonte announced they had created the first human–monkey chimera embryos. The purpose was to investigate using animals to grow human organs for transplant, using genetically matched stem cells from the recipient. Conducted in China to avoid legal restrictions in Spain.
Human–Pig (2017, USA): Scientists from the Salk Institute in California, again led by Izpisua Belmonte, attempted to grow the first embryos containing human and pig cells. From 2,075 implanted embryos, only 186 developed to the 28-day time limit. The process proved more challenging and less efficient than anticipated.
Human–Human (naturally occurring): Chimeras exist in nature. American singer Taylor Muhl discovered she was carrying the genetic material of her fraternal twin sister, whose egg had fused with hers in the womb. A large section of darker skin on her torso comes from her sister's DNA.
Virus Chimera (2017, Portugal): Portuguese researchers created a chimera virus — a mouse virus with a human viral gene — to investigate new cancer treatments caused by human herpes virus infection. The team found that when the cancer-causing virus loses a specific protein (LANA), it also loses its ability to cause cancer.
Human–Mouse (2019, Japan): Following Japan's lifting of its ban on human–animal chimeras, stem cell scientist Hiromitsu Nakauchi planned to insert human stem cells into mice or rats to attempt growing a human pancreas in the animal. A safeguard was built in: if too many human cells integrated into the rat's brain, the experiment would be stopped.
China and the Global Regulatory Split
In 2018, Chinese scientist He Jiankui announced he had created the world's first gene-edited human babies — shocking the scientific community and the world. The Chinese establishment condemned it and declared it illegal. Evidence emerged suggesting he may have received state funding. More recently, Izpisua Belmonte produced the first human–monkey hybrid embryo in China specifically to avoid legal restrictions in his adopted country, the United States.
Yet China is not alone. A scientist in Russia announced plans for more CRISPR-edited babies. Japan lifted its own ban on human–animal hybrids. The world is moving toward a two-tier research system — countries with minimal regulation on one side, countries that restrict all but the earliest stages on the other.
The consequences extend beyond research. Medical tourism, already a significant sector, will likely expand as people travel to access gene editing unavailable at home. Predatory clinics emerge to charge large sums for experimental or fraudulent treatments. And technologies with genuine promise risk having their reputations destroyed by abuses in unregulated markets before legitimate trials can demonstrate their value.
"Would people born using CRISPR be allowed to visit or emigrate to countries where their very creation was illegal?"
— David Lawrence, Newcastle University, The Conversation, September 2019
Japan rewrites its rules. Human brain cells are inserted into monkey embryos. A chimera survives to 19 days. The science moves faster than the law, faster than the ethics, and — by its own admission — faster than we are ready for.
Japan's 2019 Regulatory Change — Should We Worry?
In March 2019, Japan modified its norms regarding research with human and non-human chimeras. The amended rules allow the creation of chimeras using human brain cells, and the subsequent transfer of the resulting creature into a uterus, where it can develop for more than 14 days — potentially to term. The real consequences of this regulation in actual research remained uncertain at the time of publication, but the concerning issues were immediately identified.
◆ The 14-Day Rule — What It Was and Why Japan Crossed It
Until the 2019 amendment, Japanese regulation did not allow a chimeric embryo to develop for more than 14 days. This mirrored a rule widely accepted worldwide, derived from the 1984 Warnock Report, which prohibits research on human embryos after the 14th day of existence. The reasoning: before 14 days, the primitive streak has not yet formed and the embryo cannot be considered an individual. Embryonic division — meaning twins — is still possible before that point, so no individual exists to have moral or legal status.
The 2019 Japanese amendment allows development beyond this limit in order to allow organs to develop, and potentially to bring the chimera to term. Researchers do not yet know whether or how the chimeric embryo will develop, what it will look like, or what cognitive capacities it will possess.
The specific concern raised by the amended regulation is the use of human brain cells. A 2013 study at the University of Rochester inserted human glial cells (thinking cells) into the brains of mice. The chimeric mice tested as significantly smarter than their non-modified peers. In the first half of 2019, a Chinese study involving eleven rhesus monkeys implanted with the human MCPH1 gene — critical for brain development — showed the modified monkeys' brains developing features similar to human brains, including better short-term memory and a longer developmental period.
The central question: how many human brain cells would be necessary for an animal to develop human behaviours, and what kind of behaviours would those be? The British Academy of Medical Sciences concluded that transplanting human brain cells into animals in such a way that they adopt human-like behaviour should not be authorised. However, researchers who created the chimeric mice argued that the human cells were simply improving the efficiency of the mouse's own neural networks — not granting human-specific capabilities.
Vera Raposo, writing in JBRA Assisted Reproduction in 2020, cited researcher Hyun's assessment that no matter how developed a human–non-human chimera's brain could become, it would never reach the level of self-consciousness characteristic of humans — noting it takes several years to develop in brains that are 100% human, only under the right social and nurturing conditions of child-rearing. But Hyun also acknowledged that even if higher cognitive capacities are not sufficient to require chimeras to be treated as humans, they might still change the moral status of these entities — and therefore their legal status.
First Monkey–Human Embryos — Nature, April 2021
Scientists successfully grew monkey embryos containing human cells for the first time, reported in the journal Cell on 15 April 2021. The team, led by Juan Carlos Izpisua Belmonte at the Salk Institute, injected 132 monkey embryos with human extended pluripotent stem cells and watched them develop. Human and monkey cells divided and grew together in a dish.
Results: at 11 days after fertilisation, 91 embryos were alive. By day 17, 12 remained. By day 19, 3 were still alive — the longest any human–primate chimera had survived. Every embryo that survived contained human cells that proliferated and differentiated to varying extents. The team did not intend to implant any hybrid embryos into monkeys.
◆ The Divided Scientific Response
The work divided developmental biologists. Some questioned whether experiments involving closely related primates were necessary — non-human primates are protected by stricter research ethics rules than rodents, and experiments with livestock such as pigs and cows were described as more promising and less likely to challenge ethical limits. Alfonso Martinez Arias of Pompeu Fabra University in Barcelona noted that the rapid decline in surviving embryos as they approached day 15 suggested to him that "things are very sick."
Izpisua Belmonte argued that the goal was to understand how cells of different species communicate in early embryo development — and that observing this communication in monkey–human chimeras, which involve two more closely related species, could suggest ways to improve future human–mouse hybrid models.
Bioethicist Insoo Hyun of Case Western Reserve University acknowledged that some may see the creation of morally ambiguous entities, but noted the team had been thorough in following existing guidelines.
International guidelines were lagging. The International Society for Stem Cell Research was preparing revised guidelines for stem-cell research — addressing both non-human-primate and human chimeras. At the time, ISSCR guidelines prohibited researchers from letting human–animal chimeras mate, and recommended additional oversight when human cells could integrate with an animal host's developing central nervous system.
The regulatory landscape across nations: Japan lifted its ban and began funding chimera research in 2019. The US National Institutes of Health had announced a moratorium on federal funding for studies where human cells were injected into animal embryos in 2015. A 2016 proposal to lift the ban — but restrict research to hybrids created after gastrulation, when the early nervous system begins to form — did not resolve the issue. More than four years later, the funding ban remained in place, with the NIH awaiting updated community guidelines before acting.
"The overall message is that every embryo contained human cells that proliferate and differentiate to a different extent."
— Juan Carlos Izpisua Belmonte, Salk Institute, April 2021
◆ End of Show Notes — Human Animal Hybrids Series ◆
↑ Back to Top